Prevalence of thyrotoxicosis in Mongolia - 15/08/22
Résumé |
Aim |
To determine the prevalence of thyroid toxicity (thyrotoxicosis) in the population of Mongolia.
Method |
The survey was conducted using descriptive research methods. In order to study the prevalence of thyroid disease diagnosed nationwide, the actual number of thyroid diseases registered in 9 districts of the capital city and 330 soums of 21 aimags in 2011–2020 was collected. Thyroid disease in 330 soums and 9 districts was calculated for each aimag, soum, age group, and sex per 10,000 local population in a given year. The prevalence of thyroid disease was mapped using Arc view and GIS software.
Results |
Thyrotoxicosis is the most common thyroid disorder in Mongolia, accounting for 56.2%, with an average of 17.2 per 10,000 population in 2011–2020. In 2011, it increased 8.1 per 10,000 population, and in 2020, it increased 3 times to 25.1, and in the first 5 years, it increased 12.4 times per 10,000 population on average, and in the last 5 years it increased 21.8 times to 21.9. Thyrotoxicosis is the most common thyroid disorder in Mongolia, accounting for 56.2%, with an average of 17.2 per 10,000 population in 2011-2020. In 2011, it increased 8.1 per 10,000 population, and in 2020, it increased 3 times to 25.1, and in the first 5 years, it increased 12.4 times per 10,000 population on average, and in the last 5 years it increased 21.8 times to 21.9. In order to determine the motility of thyrotoxicosis, the disease was classified into three categories: less than 5 per 10,000 population, 5.1-10, and more than 10.1. In the last 10 years (2011–2020), less than 5 cases per 10,000 population accounted for 57% of all provinces, 20.1% for 5.1–10, and 22.1% for more than 10.1.
Conclusion |
Among thyroid disorders, thyrotoxicosis accounts for 56.2%, iodine-deficient thyroid disease for 5.5%, and other thyroid diseases for 38.3%. Compared to 5 and 5 years, in the last 5 years, more than 20.1 cases per 10,000 population have increased by 12.7% compared to the first 5 years.
Le texte complet de cet article est disponible en PDF.Plan
Vol 34 - N° 3S
P. S170-S171 - septembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.